GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
132 hedge funds and large institutions have $1.04B invested in Genomic Health, Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% more funds holding
Funds holding: 117 → 132 (+15)
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
Holders
132
Holding in Top 10
3
Calls
$1.75M
Puts
$47K
Top Buyers
| 1 | +$11M | |
| 2 | +$6.1M | |
| 3 | +$4.63M | |
| 4 |
Two Sigma Investments
New York
|
+$3.53M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
+$3.3M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$12.1M | |
| 3 | -$10M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$4.28M |
| 5 |
Morgan Stanley
New York
|
-$3.21M |